Patents Assigned to NYA Hamlet Pharma AB
  • Patent number: 7713533
    Abstract: The use of a biologically active complex of ?-lactalbumin, selected from HAMLET (human ?-lactalbumin made lethal to tumour cells) or a biologically active modification thereof, or a biologically active fragment of either of these, in the preparation of a medicament for use in the treatment of papilloma, such as cutaneous papillomas.
    Type: Grant
    Filed: August 23, 2007
    Date of Patent: May 11, 2010
    Assignee: NYA HAMLET Pharma AB
    Inventor: Catharina Svanborg
  • Patent number: 7524932
    Abstract: A method for producing an oligomeric form of ?-lactalbumin which is in the molten globule-like state is described. The method suitably comprises exposing a source of ?-lactalbumin in which the ?-lactalbumin is preferably in the molten globule-like state, to an ion exchange medium which has been pre-treated with casein or an active component thereof, such as oleic acid, and recovering ?-lactalbumin in an oligomeric form therefrom. Pre-treatment of the ion exchange medium, particularly with casein derived from human milk, has been found to significantly improve yields of the oligomeric form of ?-lactalbumin and mean that it can readily isolated from readily available sources such as bovine ?-lactalbumin. This form of ?-lactalbumin is useful therapeutically, in particular as an antibacterial agent and also as an anti-cancer therapeutic.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: April 28, 2009
    Assignee: Nya Hamlet Pharma AB
    Inventors: Catharina Svanborg, Per Anders Hakansson, Malin Wilhelmina Svensson
  • Publication number: 20080167233
    Abstract: The use of a biologically active complex of ?-lactalbumin, selected from HAMLET (human ?-lactalbumin made lethal to tumour cells) or a biologically active modification thereof, or a biologically active fragment of either of these, in the preparation of a medicament for use in the treatment of papilloma, such as cutaneous papillomas.
    Type: Application
    Filed: August 23, 2007
    Publication date: July 10, 2008
    Applicant: NYA HAMLET PHARMA AB
    Inventor: Catharina Svanborg
  • Patent number: 7270822
    Abstract: The use of a biologically active complex of ?-lactalbumin, selected from HAMLET (human ?-lactalbumin made lethal to tumour cells) or a biologically active modification thereof, or a biologically active fragment of either of these, in the preparation of a medicament for use in the treatment of papilloma, such as cutaneous papillomas.
    Type: Grant
    Filed: May 8, 2003
    Date of Patent: September 18, 2007
    Assignee: NYA Hamlet Pharma AB
    Inventor: Catharina Svanborg